鳳祥股份(09977.HK):2216.7萬股接獲H股要約有效接納 要約人持股達約72.50%
格隆匯1月13日丨鳳祥股份(09977.HK)公吿,於記錄日期(即2023年1月13日),已就2216.7萬股H股接獲H股要約的有效接納,佔於本聯合公吿日期獨立H股股東持有H股、已發行H股及已發行股份分別約6.66%、6.24%及1.58%。於記錄日期,概無接獲內資股要約的有效接納。
鑑於於記錄日期的有效接納,(a)於記錄日期,要約人及其一致行動人士擁有合共10.15億股股份的權益(佔已發行股份約72.50%)。
該等要約初步將於綜合文件日期起計21日內可供接納。首個截止日期為2023年1月18日。要約人可根據收購守則修訂或延長該等要約。要約人及山東鳳祥將於2023年1月18日下午七時正前透過聯交所網站及山東鳳祥網站聯合刊發公吿,列明該等要約是否已修訂或延長。
於除牌決議獲批准及除牌接受條件獲達成後,山東鳳祥將根據上市規則第6.12條申請將山東鳳祥於聯交所除牌。目前預期H股將於2023年2月16日下午四時正撤銷於聯交所的上市地位,但須待除牌決議獲批准及除牌接受條件獲達成,並取得有關除牌所需的任何監管批准後,方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.